- ►diabetesjournals.org Y Aso, K Okumura, K Takebayashi, S … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Plasma IL-18 was significantly higher in diabetic patients than in
control subjects (203 ± 153 vs. 118 ± 37 pg/ml, P < 0.001). High IL-18 was
defined as equaling or exceeding the mean + 2 SD of plasma IL-18 in control ... Cited by 56 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] K Esposito, F Nappo, F Giugliano, C Di Palo, M … - Diabetes Care, 2003 - Am Diabetes Assoc Our objective was to evaluate the di- agnostic proficiency of the World Health
Organization (WHO) and the National Cholesterol Education Pro- gram (NCEP)-III
definitions (1,2) for the metabolic syndrome in a Mexican nation- wide, ... Cited by 51 - Related articles - BL Direct - All 5 versions
Y Moriwaki, T Yamamoto, Y Shibutani, E Aoki … - Metabolism, 2003 - Elsevier To compare levels of interleukin (IL)-18, tumor necrosis factor-alpha
(TNF-[alpha ]), and IL-6 in serum, we studied 151 type 2 diabetes mellitus
patients with various degrees of nephropathy, as well as 80 healthy ... Cited by 93 - Related articles - BL Direct - All 7 versions
- ►endojournals.org K Esposito, A Pontillo, M Ciotola, C Di Palo, E … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc Obesity is associated with an increased risk of developing atherosclerosis,
which may be mediated, at least in part, by increased secretion of
proinflammatory cytokines by adipose tissue. We examined the hypothesis ... Cited by 112 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] K Esposito, R Marfella, D Giugliano - Diabetes Care, 2004 - Am Diabetes Assoc We read with interest the article by Aso et al. (1) showing greater plasma
concentrations of inter- leukin-18 (IL-18) in type 2 diabetic pa- tients
compared with matched control subjects. While the authors found no sig- ... Cited by 13 - Related articles - BL Direct - All 5 versions
- ►endojournals.org HF Escobar-Morreale, JI Botella-Carretero, G … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Low-grade chronic inflammation is involved in the pathogenesis of the metabolic
syndrome and atherosclerosis, and serum levels of inflammatory cytokines are
useful cardiovascular risk markers. We have studied serum IL-18 ... Cited by 76 - Related articles - BL Direct - All 5 versions
- ►eje-online.org T Skurk, H Kolb, S Muller-Scholze, K Rohrig, … - European Journal of Endocrinology, 2005 - EFES Objective: Interleukin (IL)-18, an important mediator of innate immunity and
strong risk factor for the development of cardiovascular disease, was shown
recently to be elevated in obesity. The aim of our study was to investigate ... Cited by 62 - Related articles - All 7 versions
- ►jimmunol.org Y Oikawa, A Shimada, A Kasuga, J Morimoto, T … - The Journal of Immunology, 2003 - Am Assoc Immnol IL-18 is now identified as a pleiotropic cytokine that acts as a cofactor for
both Th1 and Th2 cell development. Type 1 diabetes is considered a Th1-type
autoimmune disease, and to date, the suppressive effect of exogenous IL-18 ... Cited by 42 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org J Hung, BM McQuillan, CML Chapman, PL … - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc Methods and Results— A representative general population, aged 27 to 77 years,
without clinical diabetes was studied for clinical and biochemical risk factors
for metabolic syndrome. Serum IL-18 concentration measured in 955 subjects ... Cited by 71 - Related articles - All 9 versions
B Lindegaard, ABE Hansen, H Pilegaard, P … - Aids, 2004 - journals.lww.com The long-term toxicity of antiretroviral therapy [1], the emergence of HIV-1
drug-resistance [2,3] and the cost of long-term treatment have driven new
strategies of antiretroviral treatment including the delay of initiation of ... Cited by 19 - Related articles - BL Direct - All 4 versions
